Ratings by Cantor Fitzgerald
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 4/16/2024 | Charles Duncan | Marinus Pharmaceuticals | MRNS | Maintain | Overweight (N/A) |
13.00 (28.00) |
|
Details | |
| 4/16/2024 | Brett Knoblauch | Klaviyo Inc | KVYO | New Coverage | Overweight (N/A) |
31.00 (N/A) |
23.46 (22.73) |
-3.11% | Details |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 3,949 more... | |||||||||
